Bank of America
CRSP icon

Bank of America’s CRISPR Therapeutics CRSP Stock Holding History

Bank of America’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-168,200
Closed -$10.9M – 7545
2025
Q3 		$10.9M Sell
168,200
-85,800
-34% -$4.93M ﹤0.01% 3217
2025
Q2 		$12.4M Buy
+254,000
New +$9.83M ﹤0.01% 3023
2024
Q3 		– Sell
-50,000
Closed -$2.7M – 8202
2024
Q2 		$2.7M Hold
50,000
– – ﹤0.01% 4188
2024
Q1 		$3.41M Buy
50,000
+12,000
+32% +$859K ﹤0.01% 3991
2023
Q4 		$2.38M Buy
+38,000
New +$2.1M ﹤0.01% 4226
2023
Q3 		– Sell
-12,800
Closed -$719K – 7789
2023
Q2 		$719K Buy
+12,800
New +$726K ﹤0.01% 5011
2022
Q4 		– Sell
-678,300
Closed -$44.3M – 8244
2022
Q3 		$44.3M Buy
678,300
+194,600
+40% +$14.1M 0.01% 1345
2022
Q2 		$29.4M Buy
483,700
+483,600
+483,600% +$28.4M ﹤0.01% 1685
2022
Q1 		$6K Sell
100
-108,600
-100% -$6.82M ﹤0.01% 7855
2021
Q4 		$8.24M Sell
108,700
-326,900
-75% -$28.6M ﹤0.01% 3140
2021
Q3 		$48.8M Buy
435,600
+210,800
+94% +$26.5M 0.01% 1373
2021
Q2 		$36.4M Buy
224,800
+150,200
+201% +$18.3M ﹤0.01% 1597
2021
Q1 		$9.09M Buy
74,600
+55,800
+297% +$8.43M ﹤0.01% 2816
2020
Q4 		$2.88M Buy
+18,800
New +$2.22M ﹤0.01% 3626

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $599M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America's CRSP Position: Q1 2026 in Review

Bank of America reduced its CRISPR Therapeutics (CRSP) stake by 10% in Q1 2026, selling an estimated $6M and leaving 983,072 shares worth $46.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1645.

Bank of America first reported a position in CRSP in Q4 2016 and has held it in 38 quarters since. The position peaked at $96.1M in Q3 2022. 490 funds tracked by Wall St. Rank hold CRSP as of Q1 2026.

  • Bank of America held 983,072 shares of CRISPR Therapeutics worth $46.8M as of Q1 2026.
  • Bank of America sold 113,815 CRISPR Therapeutics shares in Q1 2026, an estimated $6M.
  • CRISPR Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1645 holding.
  • Bank of America first reported a position in CRISPR Therapeutics in Q4 2016 and has held it in 38 quarters since.
  • Bank of America's CRISPR Therapeutics position peaked at $96.1M in Q3 2022.
  • 490 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.